Asia Pacific Renal Biomarkers Market By Diagnostic Technique (Particle-Enhanced Turbidimetric Immunoassay, Colorimetric Assay, Enzyme Linked Immunosorbent Assay, Chemiluminescent Enzyme Immunoassay And Liquid Chromatography-Mass Spectrometry), By Type (Up-Regulated Proteins, Functional Biomarker And Others), By End User (Research Centres, Diagnostic Labs, Outpatient Clinics And Hospitals) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017–2022)

Asia Pacific Renal Biomarkers Market By Diagnostic Technique (Particle-Enhanced Turbidimetric Immunoassay, Colorimetric Assay, Enzyme Linked Immunosorbent Assay, Chemiluminescent Enzyme Immunoassay And Liquid Chromatography-Mass Spectrometry), By Type (Up-Regulated Proteins, Functional Biomarker And Others), By End User (Research Centres, Diagnostic Labs, Outpatient Clinics And Hospitals) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017–2022)

ID: 5411 | Pages: 145 | December 2017 | Region: Asia Pacific


The Asia Pacific Renal Biomarkers  Market is worth USD xx million in 2017 and estimated to grow at a CAGR of xx.xx%, to reach USD xx million by 2022. The Asia Pacific Renal Biomarkers market is developing at an exceptionally quick pace.

A Renal Biomarkers indicates the presence of kidney diseases by measuring blood or urine levels. Kidney diseases are one of the main reasons for death around the world.  Incidence of Chronic kidney diseases have increased due to factors like diabetes and hypertension. Advancements in technology have led to the introduction of renal biomarker which detect kidney problems accurately.

The significant drivers are rising population with kidney problems, growing incidence of renal diseases, increasing geriatric population and increasing incidence of diseases like high blood pressure and diabetes. Advancements in technology is also expected to drive the market over the forecast period. Reimbursement issues are major restraints limiting this industry.

The Asia Pacific Renal Biomarkers market is segmented on the basis of Diagnostic Technique, Type, end user and region. Based on diagnostic technique the market is segmented into Particle-Enhanced Turbidimetric Immunoassay, Colorimetric Assay, Enzyme Linked Immunosorbent Assay, Chemiluminescent Enzyme Immunoassay and Liquid Chromatography-Mass Spectrometry. Enzyme Linked Immunosorbent Assay category is expected to command the highest market share during the forecast period followed by Particle-Enhanced Turbidimetric Immunoassay. Based on type the market is segmented into Up-Regulated Proteins and Functional Biomarker. The Functional Biomarker category is expected to dominate the market. It has nearly one-half of the market share. Based on End User the market is segmented into Research Centers, Diagnostic Labs, Outpatient Clinics and Hospitals. Diagnostics Labs is expected to account for largest market share and also the fastest growth during the forecast period.

Asia Pacific is geographically segmented into China, India,Japan and South East Asia.

Abbott Diagnostics, F. Hoffmann-La Roche AG, Beckman Coulter Inc., Astute Medical Inc., Siemens Healthcare Diagnostics Inc., Thermo Fisher Scientific Inc., Alere Inc., bioMérieux SA and Randox Laboratories Ltd. are the key players in the Asia Pacific Renal Biomarkers market.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Diagnostic Technique                             

                                5.1.1 Introduction           

                                5.1.2 Chemiluminescent Enzyme Immunoassay

                                5.1.3 Colorimetric Assay               

                                5.1.4 Enzyme Linked Immunosorbent Assay       

                                5.1.5 Liquid Chromatography-Mass Spectrometry            

                                5.1.6 Particle-Enhanced Turbidimetric Immunoassay      

                                5.1.7  Y-o-Y Growth Analysis, By Diagnostic Technique   

                                5.1.8  Market Attractiveness Analysis, By Diagnostic Technique

                                5.1.9  Market Share Analysis, By Diagnostic Technique   

                5.2 Type                              

                                5.2.1 Introduction           

                                5.2.2 Up-Regulated Proteins      

                                                5.2.2.1 Interleukin 18

                                                5.2.2.2 Kidney injury molecule 1

                                                5.2.2.3 Neutrophil gelatinase-associated lipocalin

                                5.2.3 Functional Biomarker         

                                                5.2.3.1 Serum Creatinine

                                                5.2.3.2 Serum Cystatin C

                                                5.2.3.3 Urine Albumin

                                5.2.4 Others      

                                5.2.5 Y-o-Y Growth Analysis, By Type     

                                5.2.6 Market Attractiveness Analysis, By Type   

                                5.2.7 Market Share Analysis, By Type     

                5.3 End User                      

                                5.3.1 Introduction           

                                5.3.2 Diagnostic Labs      

                                5.3.3 Hospitals  

                                5.3.4 Outpatient Clinics 

                                5.3.5 Research Centres 

                                5.3.6 Y-o-Y Growth Analysis, By End User             

                                5.3.7  Market Attractiveness Analysis, By End User          

                                5.3.8  Market Share Analysis, By End User            

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Diagnostic Technique

                                                6.1.3.3 By Type

                                                6.1.3.4 By End User

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Diagnostic Technique

                                                6.1.4.3 By Type

                                                6.1.4.4 By End User

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Diagnostic Technique

                                                6.1.5.3 By Type

                                                6.1.5.4 By End User

                6.2 China                             

                6.3 India                              

                6.4 Japan                            

                6.5 South Korea                               

                6.6 Australia                      

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Thermo Fisher Scientific Inc                 

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Abbott Laboratories                               

                8.3 Beckman Coulter, Inc.                            

                8.4 Randox Laboratories Ltd                       

                8.5 Astute Medical Inc.                 

                8.6 F. Hoffmann-La Roche AG                    

                8.7 Siemens Healthcare Diagnostics Inc.                

                8.8 Alere Inc.                     

                8.9 bioMérieux SA                          

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms Diagnostic Technique and Type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Asia Pacific Renal Biomarker Market By Diagnostic Technique, From 2017-20222 ( USD Million )
  2. Asia Pacific Enzyme Linked Immunosorbent Assay Market By Region, From 2017-20222 ( USD Million )
  3. Asia Pacific Chemiluminescent Enzyme Immunoassay Market By Region, From 2017-20222 ( USD Million )
  4. Asia Pacific Colorimetric Assay Market By Region, From 2017-20222 ( USD Million )
  5. Asia Pacific Liquid Chromatography-Mass Spectrometry Market By Region, From 2017-20222 ( USD Million )
  6. Asia Pacific Particle-Enhanced Turbidimetric Immunoassay Market By Region, From 2017-20222 ( USD Million )
  7. Asia Pacific Renal Biomarker Market By Biomarker Type, From 2017-20222 ( USD Million )
  8. Asia Pacific Up-Regulated Proteins Market By Region, From 2017-20222 ( USD Million )
  9. Asia Pacific Functional Biomarker Market By Region, From 2017-20222 ( USD Million )
  10. Asia Pacific Renal Biomarker Market By End User, From 2017-20222 ( USD Million )
  11. Asia Pacific Diagnostic Labs Market By Region, From 2017-20222 ( USD Million )
  12. Asia Pacific Hospitals Market By Region, From 2017-20222 ( USD Million )
  13. Asia Pacific Outpatient Clinics Market By Region, From 2017-20222 ( USD Million )
  14. Asia Pacific Research Centres Market By Region, From 2017-20222 ( USD Million )
  15. Japan Renal Biomarker Market By Diagnostic Technique, From 2017-20222 ( USD Million )
  16. Japan Renal Biomarker Market By Biomarker Type, From 2017-20222 ( USD Million )
  17. Japan Renal Biomarker Market By End User, From 2017-20222 ( USD Million )
  18. China Renal Biomarker Market By Diagnostic Technique, From 2017-20222 ( USD Million )
  19. China Renal Biomarker Market By Biomarker Type, From 2017-20222 ( USD Million )
  20. China Renal Biomarker Market By End User, From 2017-20222 ( USD Million )
  21. India Renal Biomarker Market By Diagnostic Technique, From 2017-20222 ( USD Million )
  22. India Renal Biomarker Market By Biomarker Type, From 2017-20222 ( USD Million )
  23. India Renal Biomarker Market By End User, From 2017-20222 ( USD Million )
  24. Australia Renal Biomarker Market By Diagnostic Technique, From 2017-20222 ( USD Million )
  25. Australia Renal Biomarker Market By Biomarker Type, From 2017-20222 ( USD Million )
  26. Australia Renal Biomarker Market By End User, From 2017-20222 ( USD Million )
  27. South Korea Renal Biomarker Market By Diagnostic Technique, From 2017-20222 ( USD Million )
  28. South Korea Renal Biomarker Market By Biomarker Type, From 2017-20222 ( USD Million )
  29. South Korea Renal Biomarker Market By End User, From 2017-20222 ( USD Million )
Middle-East And Africa Cell Counting Market By Product [(Instruments (Cell Counters, Hematology Analysers, Spectrophotometer, Flow Cytometer, Hemocytometer, Others), Consumables (Microplates, Reagent, Assay Kits)], ...
Latin America Cell Counting Market By Product [(Instruments (Cell Counters, Hematology Analysers, Spectrophotometer, Flow Cytometer, Hemocytometer, Others), Consumables (Microplates, Reagent, Assay Kits)], End User ...
Asia-Pacific Cell Counting Market By Product [(Instruments (Cell Counters, Hematology Analysers, Spectrophotometer, Flow Cytometer, Hemocytometer, Others), Consumables (Microplates, Reagent, Assay Kits)], End User (...
Europe Cell Counting Market By Product [(Instruments (Cell Counters, Hematology Analysers, Spectrophotometer, Flow Cytometer, Hemocytometer, Others), Consumables (Microplates, Reagent, Assay Kits)], End User (Pharma...
North America Cell Counting Market By Product [(Instruments (Cell Counters, Hematology Analysers, Spectrophotometer, Flow Cytometer, Hemocytometer, Others), Consumables (Microplates, Reagent, Assay Kits)], End User ...
Cell Counting Market By Product [(Instruments (Cell Counters, Hematology Analysers, Spectrophotometer, Flow Cytometer, Hemocytometer, Others), Consumables (Microplates, Reagent, Assay Kits)], End User (Pharmaceutica...
Middle East And Africa Non-Invasive Cancer Diagnostics Market By Techniques (Clinical Chemistry, Immunochemistry, Molecular Diagnostics And Others), By Therapeutics (Blood Cancer, Breast Cancer, Lung Cancer, Solid T...
Latin America Non-Invasive Cancer Diagnostics Market By Techniques (Clinical Chemistry, Immunochemistry, Molecular Diagnostics And Others), By Therapeutics (Blood Cancer, Breast Cancer, Lung Cancer, Solid Tumors And...
Asia Pacific Non-Invasive Cancer Diagnostics Market By Techniques (Clinical Chemistry, Immunochemistry, Molecular Diagnostics And Others), By Therapeutics (Blood Cancer, Breast Cancer, Lung Cancer, Solid Tumors And ...
Europe Non-Invasive Cancer Diagnostics Market By Techniques (Clinical Chemistry, Immunochemistry, Molecular Diagnostics And Others), By Therapeutics (Blood Cancer, Breast Cancer, Lung Cancer, Solid Tumors And Others...
North America Non-Invasive Cancer Diagnostics Market By Techniques (Clinical Chemistry, Immunochemistry, Molecular Diagnostics And Others), By Therapeutics (Blood Cancer, Breast Cancer, Lung Cancer, Solid Tumors And...
Non-Invasive Cancer Diagnostics Market By Techniques (Clinical Chemistry, Immunochemistry, Molecular Diagnostics And Others), By Therapeutics (Blood Cancer, Breast Cancer, Lung Cancer, Solid Tumors And Others) And B...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.